Item 9 Labs Corp. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Item 9 Labs Corp. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2011 to Q2 2023.
  • Item 9 Labs Corp. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2023 was $968K, a 63.7% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $968K +$377K +63.7% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 $596K -$581K -49.4% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 $602K -$1.02M -62.9% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $586K -$862K -59.5% Sep 30, 2022 10-Q 2023-08-21
Q2 2022 $592K -$1.46M -71.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.18M -$1.39M -54.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.62M +$168K +11.5% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $1.45M +$1.1M +311% Sep 30, 2021 10-K 2023-01-13
Q2 2021 $2.06M +$1.45M +239% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $2.57M +$2M +356% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $1.45M +$1.09M +297% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $353K -$84.4K -19.3% Sep 30, 2020 10-K 2022-01-13
Q2 2020 $606K +$210K +53.1% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $563K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $367K Dec 31, 2019 10-Q 2020-02-19
Q3 2019 $437K +$340K +349% Sep 30, 2019 10-K 2021-01-12
Q2 2019 $396K Jun 30, 2019 10-Q 2019-08-16
Q3 2018 $97.4K Sep 30, 2018 10-K 2020-01-14
Q1 2016 $530* $0 0% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $530* -$85.8K -99.4% Dec 31, 2015 10-Q 2016-03-28
Q3 2015 $530* -$2.61K -83.1% Sep 30, 2015 10-Q 2016-08-19
Q2 2015 $530* -$29.4K -98.2% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $530* -$27.1K -98.1% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 $86.4K +$57.1K +195% Dec 31, 2014 10-Q 2015-02-20
Q3 2014 $3.14K -$31.9K -91% Sep 30, 2014 10-K 2016-03-04
Q2 2014 $30K +$6.49K +27.6% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $27.7K -$109K -79.7% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $29.3K -$22.2K -43.1% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $35K -$576K -94.3% Sep 30, 2013 10-K 2015-01-09
Q2 2013 $23.5K Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $136K +$120K +719% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $51.5K +$44.7K +656% Dec 31, 2012 10-QT 2013-02-19
Q3 2012 $611K Sep 30, 2012 10-K 2014-01-13
Q1 2012 $16.6K Mar 31, 2012 10-Q/A 2012-10-25
Q4 2011 $6.81K Dec 31, 2011 10-Q/A 2012-10-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.